CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 47 enrolled
Drug / intervention
vitamin D +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02197702
NCT02197702Phase 3Completed

Vitamin D In the Prevention of Viral-induced Asthma of Preschoolers: a Randomised Controlled Trial (RCT)- (DIVA)

St. Justine's Hospital·interventional·Posted Jul 23, 2014·Updated Dec 9, 2024

In Brief

A Phase 3 clinical trial evaluating vitamin D and placebo for Asthma. Completed, enrolled 47 participants across 1 site.

Detailed Summary

In this 7-month randomized controlled trial, children aged 1-6 years with asthma attacks triggered mostly by colds, will receive a high dose of vitamin D or a placebo every 3.5 months during their usual clinic visit. This study will test whether children receiving a high dose of vitamin D have less frequent and less severe asthma exacerbations compared with those receiving placebo.The study will also document the safety profile of this strategy.

Study Details

Timeline

Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 23, 2014
Enrollment StartSep 1, 2014
Primary CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.9 years ago

Interventions

vitamin Ddietary

Two doses of cholecalciferol 100,000 unit (2 mL) given 3.5 months apart, once in the fall, once in the winter

placebodietary

Two doses of identical placebo (2 mL) given 3.5 months part, once in the fall, once in the winter